Market research
47M.F MedMira Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 26M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.76
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- CA58501R1029
- Market cap
- 26M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.76
About
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 47M.F discussion.
5 years, 5 months ago
MedMira Inc is currently in a long term downtrend where the price is trading 37.0% below its 200 day moving average.
From a valuation standpoint, the stock is 95.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 65.8.
MedMira Inc's total revenue rose by 1587.0% to $2M since the same quarter in the previous year.
Its net income has increased by 216.4% to $715K since the same quarter in the previous year.
Finally, its free cash flow grew by 11.8% to $-363K since the same quarter in the previous year.
Based on the above factors, MedMira Inc gets an overall score of 4/5.